Therefore, in this study, our results indicated that the observed inhibition of mesangial cell expansion in diabetic nephropathy mice treated with VPA may not be due to the activating effect of VPA on the GM3 synthase gene (St3gal5). Here, ST3GAL5 is linked to diabetic kidney disease.